Larimar Therapeutics (LRMR) Change in Acquisitions & Divestments (2015 - 2025)

Larimar Therapeutics' Change in Acquisitions & Divestments history runs 11 years deep, the most recent figure standing at $34.0 million for Q4 2025.

• Quarterly Change in Acquisitions & Divestments fell 41.38% year-over-year to $34.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $184.0 million (up 28.67% YoY) and the FY2025 annual result came in at $184.0 million, up 28.67% from the prior year.
• Change in Acquisitions & Divestments was $34.0 million for Q4 2025 at Larimar Therapeutics, down from $36.5 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $92.2 million in Q1 2023 and bottomed at $9000.0 in Q2 2023.
• A 5-year average of $32.1 million and a median of $26.1 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
• Peak annual rise in Change in Acquisitions & Divestments reached 205455.56% in 2024, while the deepest fall reached 82.11% in 2024.
• Larimar Therapeutics' Change in Acquisitions & Divestments stood at $6.5 million in 2021, then soared by 203.85% to $19.8 million in 2022, then surged by 64.56% to $32.5 million in 2023, then surged by 78.46% to $58.0 million in 2024, then plunged by 41.38% to $34.0 million in 2025.
• Business Quant data shows LRMR's Change in Acquisitions & Divestments at $34.0 million in Q4 2025, $36.5 million in Q3 2025, and $46.5 million in Q2 2025.